Abcellera Biologics Inc (ABCL) — Cash Flow Reinvestment Rate
Abcellera Biologics Inc (ABCL) has a Cash Flow Reinvestment Rate of 1.89x as of June 2023, reinvesting $37.52 Million (capex $27.35 Million plus investments $-10.17 Million) from operating cash flow of $19.82 Million. Explore Abcellera Biologics Inc (ABCL) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Abcellera Biologics Inc Cash Flow Reinvestment Rate (2018–2022)
Historical reinvestment intensity for Abcellera Biologics Inc across 5 annual periods. Also explore Abcellera Biologics Inc (ABCL) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Abcellera Biologics Inc (2018–2022)
Year-by-year capital reinvestment analysis for Abcellera Biologics Inc. For live market cap and broader valuation context, see market value of Abcellera Biologics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.53x | $425.29 Million | $277.36 Million | $72.66 Million | ▲ +11.7% |
| 2021 | 1.37x | $335.88 Million | $244.58 Million | $58.45 Million | ▼ -8.1% |
| 2020 | 1.49x | $33.92 Million | $22.69 Million | $14.67 Million | ▼ -58.8% |
| 2019 | 3.63x | $9.78 Million | $2.69 Million | $4.00 Million | ▲ +21.9% |
| 2018 | 2.98x | $10.61 Million | $3.56 Million | $5.31 Million | — |